# Mass Source Activation Agent Council Final Review

Date: 2026-06-15

Subagents were emulated manually in this Codex session. No 11th active agent was added.

## Chief of Staff

Status: pass

- Scope remained controlled.
- No infrastructure, deployment, broad monitoring, customer delivery, or all-source run occurred.
- New work focused on docs, queue state machine, validator, tests, and one CLI help correction.

## Product Manager

Status: pass

- The work improves the buyer-relevant path to batch activation by preventing vanity source-count padding.
- The queue centers official/regulatory source relevance and keeps weak candidates in remediation/candidate states.

## Code Architect

Status: pass

- Implementation is additive and dependency-light.
- No parser rewrite, database migration, or active registry expansion.
- `mass_source_activation.py` is a pure state-evaluation module and does not fetch, save, alert, or mutate `sources.json`.

## QA / Critic

Status: pass

- New tests cover no-save/evidence/baseline/gate activation boundaries.
- New validator blocks fake activation-ready states and confirms public truth remains 13/9/4.
- No source was promoted from the live checks.

## Legal Language

Status: pass

- No customer-facing copy was changed.
- Forbidden claims remain blocked by validators: any website, perfect parsing, 50/60 working/validated before proof, legal advice, guaranteed compliance, regulator certification.

## Source Monitor

Status: pass

- Source-health/noise fields are required in the mass queue.
- Queue entries preserve remediation/blocked status for SCA, CBUAE, VARA, and candidate states for untested sources.
- SCA, DFSA, ADGM, CBUAE, and VARA live results were recorded honestly.

## Evidence Trail

Status: pass

- No evidence was saved in this sprint.
- Activation-ready requires proof path and repeat baseline.
- One no-save extraction for ADGM did not become evidence or activation-ready.

## Risk + Brief Pipeline

Status: pass

- No brief/risk workflow was triggered.
- The architecture keeps brief eligibility downstream of proof and evidence completeness.

## ICP Lead Research

Status: pass

- Queue targets focus on MLRO/CCO-relevant UAE regulators and compliance surfaces.
- Generic source padding remains blocked.

## Outreach Writer

Status: not used

- No outreach or public marketing copy was changed.
